Selvita provides its clients with effective drug discovery support based on broad capabilities and deep experience in small molecule drug discovery, starting from target validation up to the selection of a clinical candidate. We powerfully execute fully-integrated drug discovery programs combining all of Selvita’s core skills in biology and chemistry or else provide partially-integrated or stand-alone services utilising selected capabilities optimally matched to the specific needs of our clients.
Selvita is built on robust capabilities and experience in assay development and screening, high-throughput screening, high content screening, medicinal and synthetic chemistry, computer-aided drug design, structural biology, in vitro and in vivo pharmacology, ADME/DMPK, toxicology and analytical testing. In collaboration with proven and experienced partners, we also offer pharmacological and efficacy testing with in vivo models of disease available for variety of indications. Our daughter company, Ardigen, supports us in increasing the speed and reducing the cost of drug discovery process by using Artificial Intelligence tools.
Selvita has already proven its impact on the global innovation. Through a great number of projects executed for over 10 years, we have contributed to impactful discoveries in various areas. Our scientific team have built strong partnerships on out-of-the-box thinking and become an integral part of our clients’ organizations ensuring, strong IP protection and goal achievement.